Serum Institute plans to cut monthly production of Covishield by 50%

1 430

The country has administered 114.78 crore vaccines of the Covishield vaccines till date. SII has exported seven crore doses of the Covishield. Serum Institute of India (SII) is planning to cut monthly production of Covishield by 50%, if it does not receive any fresh orders either from the government or from export markets. Adar Poonawalla, … Read more

Serum seeks regulatory nod for Ph-III trials of Novavax’s Covid vaccine

serum1200

Novavax’s development is two months behind that of AstraZenca. Serum Institute of India (SII) may soon start Phase-III trials of another Covid-19 vaccine being developed by US-based biotechnology company Novavax. SII is seeking regulatory nod from the Indian government to start the trials for this vaccine. Company sources said it can start the trials by … Read more